Re-analysis of genetic risks for Chronic Fatigue Syndrome from 23andMe data finds few remain
Felice L. Bedford, Bastian Greshake Tzovaras
doi: https://doi.org/10.1101/2020.10.27.20220939
Felice L. Bedford
1University of Arizona, Tucson, AZ, USA
Bastian Greshake Tzovaras
2Université de Paris, Paris, France

Article usage
Posted October 31, 2020.
Re-analysis of genetic risks for Chronic Fatigue Syndrome from 23andMe data finds few remain
Felice L. Bedford, Bastian Greshake Tzovaras
medRxiv 2020.10.27.20220939; doi: https://doi.org/10.1101/2020.10.27.20220939
Subject Area
Subject Areas
- Addiction Medicine (269)
- Allergy and Immunology (552)
- Anesthesia (135)
- Cardiovascular Medicine (1752)
- Dermatology (172)
- Emergency Medicine (312)
- Epidemiology (10792)
- Gastroenterology (586)
- Genetic and Genomic Medicine (2939)
- Geriatric Medicine (287)
- Health Economics (532)
- Health Informatics (1921)
- Health Policy (835)
- Hematology (291)
- HIV/AIDS (628)
- Medical Education (299)
- Medical Ethics (86)
- Nephrology (324)
- Neurology (2791)
- Nursing (151)
- Nutrition (432)
- Oncology (1460)
- Ophthalmology (443)
- Orthopedics (172)
- Otolaryngology (255)
- Pain Medicine (190)
- Palliative Medicine (56)
- Pathology (380)
- Pediatrics (865)
- Primary Care Research (336)
- Public and Global Health (5350)
- Radiology and Imaging (1009)
- Respiratory Medicine (726)
- Rheumatology (329)
- Sports Medicine (278)
- Surgery (327)
- Toxicology (47)
- Transplantation (149)
- Urology (125)